CARDIOL THERAPEUTICS INC. (CRDL)
Clinical trial NCT05406284 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-12-30 → 2026-07-30 3. enrollment: 12 → 43 participants 4. enrollment type: ESTIMATED → ACTUAL 5. collaborators added: Turkish Society of Cardiology
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical